海泰新光收盘上涨2.57%，滚动市盈率29.21倍，总市值41.94亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Qindao Haitai Newlight Technology Co., Ltd. in the medical device industry, particularly focusing on its financial metrics and stock performance [1][2] - As of April 28, the company's stock closed at 34.77 yuan, with a 2.57% increase, and a rolling PE ratio of 29.21, marking a 17-day low, with a total market capitalization of 4.194 billion yuan [1] - The average PE ratio for the medical device industry is 46.40, with a median of 34.81, placing Haitai Newlight at the 69th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, 26 institutions hold shares in Haitai Newlight, including 22 funds, 3 other entities, and 1 social security fund, with a total holding of 57.068 million shares valued at 2.145 billion yuan [1] - The company specializes in the research, production, sales, and service of medical endoscope instruments and optical products, with key products including high-definition fluorescent endoscopes and accessories [1] - The latest financial report for Q1 2025 shows the company achieved a revenue of 147 million yuan, a year-on-year increase of 24.86%, and a net profit of 46.6887 million yuan, up 21.45%, with a gross profit margin of 64.98% [1]